Even though this group exhibits no phenotypical abnormalities, it has been reported that ATM heterozygotes have a high risk of developing breast cancer, with about a 5-fold increase compared with the general population [160,168,169,170,171,172,173]. This evidence concerns the gene ATM and breast carcinoma.